|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Dec 23, 2010 |
Title |
A human iPSC model of Hutchinson Gilford Progeria Syndrome reveals a possible mesenchymal stem cell defect |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Hutchinson Gilford Progeria Syndrome (HGPS) is a rare, sporadic genetic disease caused by mutations in the nuclear lamin A gene. In most cases the mutation creates an efficient donor-splice site that generates an altered transcript encoding a truncated lamin A protein, progerin. In vitro studies have indicated that progerin can disrupt nuclear function. HGPS affects mainly mesenchymal lineages but the shortage of patient material has precluded a tissue-wide molecular survey of progerin’s cellular impact. We report here a new, induced pluripotent stem cell (iPSC)-based model for studying HGPS. HGPS dermal fibroblasts were reprogrammed into iPSC lines using a cocktail of the transcription factor genes, OCT4, SOX2, KLF4 and C-MYC. The iPSC cells were differentiated into neural progenitors (NPs), endothelial cells (ECs), fibroblast-like cells and mesenchymal stem cells (MSCs). Progerin levels in the different cell types followed the pattern MSC≥ fibroblast>EC>>NP. Functionally, we detected a major impact of progerin on MSC function. We show that HGPS-MSCs are vulnerable to the ischemic conditions found in a murine hind limb recovery model and an in vitro hypoxia assay, as well as showing enhanced sensitivity in a serum starvation assay. Since there is widespread consensus that MSCs reside in low oxygen niches in vivo, we propose that these conditions lead to an accelerated depletion of the MSC pool in HGPS patients with consequent accretion of mesenchymal tissue.
|
|
|
Overall design |
Analysis of iPSCs, hESCs and parental fibroblasts at the gene expression level. The comparison analysis in the present study was expected to show the similarity between iPSCs, hESCs and parental fibroblasts. Results provide important information of the differences between iPSCs, hESCs and parental fibroblasts. Total RNA was obtained from different samples (iPSCs, hESCs, and fibroblasts) separately.
|
|
|
Contributor(s) |
Zhang J, Lian Q, Zhu G, Zhou F, Sui L, Tan C, Mutalif RA, Navasankari R, Zhang Y, Tse H, Stewart C, Colman A |
Citation(s) |
21185252 |
|
Submission date |
Dec 15, 2010 |
Last update date |
Mar 20, 2017 |
Contact name |
FAN ZHOU |
E-mail(s) |
zhou.fan@imb.a-star.edu.sg
|
Phone |
+65-64070217
|
Fax |
+65-64072048
|
Organization name |
Institute of Medical Biolog
|
Lab |
STEM CELL DISEASE MODEL
|
Street address |
8A Biomedical Grove
|
City |
Singapore |
ZIP/Postal code |
138648 |
Country |
Singapore |
|
|
Platforms (1) |
GPL6883 |
Illumina HumanRef-8 v3.0 expression beadchip |
|
Samples (23)
|
|
Relations |
BioProject |
PRJNA135167 |
Supplementary file |
Size |
Download |
File type/resource |
GSE26093_RAW.tar |
3.9 Mb |
(http)(custom) |
TAR |
GSE26093_non-normalized.txt.gz |
2.1 Mb |
(ftp)(http) |
TXT |
Processed data included within Sample table |
|
|
|
|
|